Global IVD Market Report 2021 with COVID-19 Impacts (Q3 2020 to Q1 2021)

Dublin, May 04, 2021 (GLOBE NEWSWIRE) -- The "2021 IVD Market Update and COVID-19 Impact" report has been added to ResearchAndMarkets.com's offering.

This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from the report's analysts to reflect the latest information.

Key Questions Answered:

• What is the Size of the IVD Market in 2021?

• What Impact has COVID-19 Had on IVD Markets?

• What Major Trends are Affecting the Market in 2021?

As part of its coverage, this report contains market sizing for the following categories of IVD:

• Clinical Chemistry

• Immunoassays- non isotopic

• Infectious disease

• Other immunos

• Blood bank screening

• Drugs of Abuse

• Diabetes HbA1c - lab

• Hematology - Core Lab

• Microbiology (ID/AST)

• Microbiology (molecular)

• Microbiology - Mass Spectrometry

• Radioimmunoassays

• Coagulation (PT/INR)

• Coagulation, molecular

• Histology/cytology

• HPV, molecular

• Nucleic acid assays

• Blood grouping/typing

• Blood bank molecular

• NAT Blood Screens

• Circulating tumor cells

• POC, OTC diabetes

• POC, OTC other

• POC, professional/hospital;

• COVID 19

Complete market figures and forecasts will be part of the Worldwide report in August.

How is COVID-19 Impacting the Market in 2021

This report does detail the effects of COVID-19 including the following:

• Effect of COVID-19 on Market Segments

• IVD Market excluding and with COVID-19, 2020

• IVD Market Distribution by Segment

• Global In Vitro Diagnostic Market - YoY Growth 2019-2020

• Global In Vitro Diagnostic Market - YoY Growth 2019-2020

• IVD Segment Performance, Q1 2020 - Q4 2020

• IVD Segment Performance, Total Market Value, 2020

Also included in this report:

• Product Trends and Developments

• COVID-19 Developments Sept. 2020 to Feb 2021

• Select IVD Market Participant Developments

• Competitive Leader Updates

Key Topics Covered:

ONE: WORLDWIDE IVD MARKET - 2020 UPDATE

COVID 19

IVD MARKET HIGHLIGHTS AND EFFECTS OF COVID-19

• Effect of COVID-19 on Market Segments

TWO: PRODUCT TRENDS AND NEW DEVELOPMENTS

• NEW CORE IVD PRODUCT LAUNCHES AND DEVELOPMENTS

  • Clinical Chemistry

  • Hematology

  • Oncology

  • Coagulation

  • Immunoassay

  • Microbiology

  • Histology

  • Molecular Specialties

  • POC

  • Mass Spectrometry

• COVID-19 DEVELOPMENTS - SEPTEMBER 2020 - FEBRUARY 2021

• Antigen

• Serology

• Molecular

THREE: SELECTED IVD MARKET PARTICIPANT DEVELOPMENTS

• SELECTED COMPETITIVE LEADER UPDATES

  • IVD Segment Growth by Leading Competitors, Change in Sales 2019-2020

  • Changes in Market Distribution for IVD Sales, 2019-2020 - Roche Maintains Lead, Abbott Closing Gap

• Abbott

• Aidian Oy

• Becton Dickinson and Co

• Biomerieux SA

• Danaher

• Hologic, Inc.

• Illumina

• Ortho Clinical Diagnostics

• Perkin Elmer

• Quidel Corporation

• Roche Diagnostic

• Thermo Fisher Scientific

FOUR: NEW OPPORTUNITIES

• Telehealth and Remote Patient Monitoring

• Expanding Options in Reimbursement

• POC

For more information about this report visit https://www.researchandmarkets.com/r/9mobgz

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900